Can better sleep and bright light lift teen depression?

NCT ID NCT06963463

Recruiting now Symptom relief Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a sleep-focused program (TranS-C) plus bright light therapy in 90 teens aged 12-18 with moderate to severe depression and sleep problems. Half get the full program with a sleep therapist and light glasses; the other half just track their sleep. The goal is to see if the program is feasible and acceptable, and if it improves sleep and mood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transdiagnostic Sleep and Circadian Intervention (TranS-C) plus bright light therapy and blue-blocking glasses
What this could lead to: If it works, this could point toward a simple, non-drug way to ease depression and sleep problems in teens, potentially reducing suicide risk.
What could go wrong: This is an early feasibility study with only 90 participants, so results may not apply to everyone. The intervention is time-intensive, and benefits may be modest or not last.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADOLESCENT DEPRESSION WITH SUICIDAL THOUGHTS AND BEHAVIOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder major depressive disorder Parasomnias sleep disorder Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION SLEEP SLEEP DISTURBANCE SUICIDE

Contacts and locations

Locations

Childrens Hospital of Philadelphia
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
University of Pittsburgh
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.